Viewing Study NCT06060405


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2025-12-26 @ 1:58 AM
Study NCT ID: NCT06060405
Status: RECRUITING
Last Update Posted: 2024-01-08
First Post: 2023-09-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Durvalumab and Oleclumab in Resectable PDAC
Sponsor:
Organization: